PT964863E - Oxazolidinonas como antagonistas de 5-ht2a - Google Patents

Oxazolidinonas como antagonistas de 5-ht2a

Info

Publication number
PT964863E
PT964863E PT98909397T PT98909397T PT964863E PT 964863 E PT964863 E PT 964863E PT 98909397 T PT98909397 T PT 98909397T PT 98909397 T PT98909397 T PT 98909397T PT 964863 E PT964863 E PT 964863E
Authority
PT
Portugal
Prior art keywords
oxazolidinones
ht2a antagonists
ht2a
antagonists
Prior art date
Application number
PT98909397T
Other languages
English (en)
Portuguese (pt)
Inventor
Christoph Seyfried
Helmut Prucher
Gerd Bartoszyk
Henning Bottcher
Helmut Greiner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT964863E publication Critical patent/PT964863E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT98909397T 1997-02-26 1998-02-06 Oxazolidinonas como antagonistas de 5-ht2a PT964863E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19707628A DE19707628A1 (de) 1997-02-26 1997-02-26 Oxazolidinone

Publications (1)

Publication Number Publication Date
PT964863E true PT964863E (pt) 2003-10-31

Family

ID=7821498

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98909397T PT964863E (pt) 1997-02-26 1998-02-06 Oxazolidinonas como antagonistas de 5-ht2a

Country Status (25)

Country Link
US (1) US6462056B1 (OSRAM)
EP (1) EP0964863B1 (OSRAM)
JP (2) JP4402175B2 (OSRAM)
KR (1) KR20000075697A (OSRAM)
CN (1) CN1177847C (OSRAM)
AR (1) AR010899A1 (OSRAM)
AT (1) ATE240954T1 (OSRAM)
AU (1) AU739251B2 (OSRAM)
BR (1) BR9807765A (OSRAM)
CA (1) CA2281918C (OSRAM)
CZ (1) CZ299199A3 (OSRAM)
DE (2) DE19707628A1 (OSRAM)
DK (1) DK0964863T3 (OSRAM)
ES (1) ES2197466T3 (OSRAM)
HU (1) HUP0001093A3 (OSRAM)
ID (1) ID22838A (OSRAM)
NO (1) NO313415B1 (OSRAM)
PL (1) PL335100A1 (OSRAM)
PT (1) PT964863E (OSRAM)
RU (1) RU2196140C2 (OSRAM)
SK (1) SK112799A3 (OSRAM)
TW (1) TW531538B (OSRAM)
UA (1) UA58542C2 (OSRAM)
WO (1) WO1998038189A1 (OSRAM)
ZA (1) ZA981579B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
TR200101939T2 (tr) * 1999-01-28 2002-05-21 Bristol-Myers Squibb Company Antidepresan heterosiklik bileşikler
ES2165274B1 (es) 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
EP1106605A4 (en) * 1999-06-24 2005-12-07 Toray Industries ANTAGONISTS OF THE ADRENERGIC RECEPTOR-ALPHA1B
GB9928568D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2002081470A1 (en) * 2001-04-07 2002-10-17 Astrazeneca Ab Oxazolidinones containing a sulfonimid group as antibiotics
MXPA04007067A (es) * 2002-01-22 2004-11-01 Upjohn Co Dispositivos medicos resistentes a infecciones.
JPWO2004069828A1 (ja) * 2003-02-04 2006-05-25 三菱ウェルファーマ株式会社 ピペリジン化合物およびその医薬用途
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CL2008001002A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
RU2492169C2 (ru) * 2007-12-18 2013-09-10 Актелион Фармасьютиклз Лтд Производные 5-аминоциклилметилоксазолидин-2-она
MX2011003188A (es) * 2008-10-10 2011-04-27 Actelion Pharmaceuticals Ltd Antibioticos de oxazolidinilo.
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DK152090D0 (da) 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
CA2100376A1 (en) * 1992-07-14 1994-01-15 Mitsuo Masaki Alkylenediamine derivatives
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate

Also Published As

Publication number Publication date
ATE240954T1 (de) 2003-06-15
HUP0001093A3 (en) 2001-07-30
TW531538B (en) 2003-05-11
NO994106L (no) 1999-10-19
NO994106D0 (no) 1999-08-25
CA2281918C (en) 2007-04-03
CA2281918A1 (en) 1998-09-03
PL335100A1 (en) 2000-04-10
JP2001513764A (ja) 2001-09-04
DE59808461D1 (de) 2003-06-26
RU2196140C2 (ru) 2003-01-10
AR010899A1 (es) 2000-07-12
JP4402175B2 (ja) 2010-01-20
KR20000075697A (ko) 2000-12-26
US6462056B1 (en) 2002-10-08
CN1177847C (zh) 2004-12-01
DK0964863T3 (da) 2003-08-04
DE19707628A1 (de) 1998-08-27
AU739251B2 (en) 2001-10-04
UA58542C2 (uk) 2003-08-15
AU6394998A (en) 1998-09-18
SK112799A3 (en) 2000-06-12
EP0964863A1 (de) 1999-12-22
JP2009256363A (ja) 2009-11-05
WO1998038189A1 (de) 1998-09-03
CN1248973A (zh) 2000-03-29
ES2197466T3 (es) 2004-01-01
EP0964863B1 (de) 2003-05-21
HUP0001093A2 (hu) 2001-06-28
ID22838A (id) 1999-12-09
BR9807765A (pt) 2000-02-22
ZA981579B (en) 1999-03-17
NO313415B1 (no) 2002-09-30
CZ299199A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
IT1308096B1 (it) Convertiplano
EP0986385A4 (en) GONADORELIN ANTAGONISTS
PT1379511E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepin-2-ona como antagonistas ii de r2glum
PT1218359E (pt) Compostos de piperazina uteis como antagonistas de taquiquininas
PT1084114E (pt) Derivados isotiazole uteis como agentes anticancerigenos
BR9707391A (pt) Pirazolpirimidinas como antagonistas de receptor de crf
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
PT818454E (pt) Derivados de benzimidazole com actividade anti-histaminica
ATE317652T1 (de) Zahnbürste
PT1028961E (pt) Derivados de pleuromutilina como agentes antimicrobianos
ATE261679T1 (de) Zahnbürste
DE60036430D1 (de) Werkzeughalter
ATE264633T1 (de) Zahnbürste
PT1379522E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepina-2-ona como antagonistas i do r2glum
DE60038157D1 (de) Baumaschine
PT975623E (pt) Compostos indazolamida utilizados como agentes serotoninergicos
PT1218009E (pt) Grandulos de quetiapina
DE50009640D1 (de) Drehmaschine
DE69718786D1 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
PT1027342E (pt) Derivados de ciclopentenos uteis como antagonistas do receptor da motilina
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
PT1218096E (pt) Microcapsulas de libertacao variavel
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
ATE289496T1 (de) Zahnbürste
PT1216250E (pt) Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4